Market Place
Sourcing Support
Traws Publishes Rigosertib Data in RDEB SCC Patients
03 Jun 2025 //
GLOBENEWSWIRE
Traws Pharma Gets FDA Guidance for Tivoxavir, Eyes Stockpile
27 May 2025 //
GLOBENEWSWIRE
Traws Pharma Reports Q1 2025 Results and Business Highlights
15 May 2025 //
GLOBENEWSWIRE
Traws Pharma Reports 2024 Results and Business Highlights
31 Mar 2025 //
GLOBENEWSWIRE
Traws Pharma Announces Management Updates
28 Mar 2025 //
GLOBENEWSWIRE
Traws Pharma Investor Event on Bird Flu & COVID Products, March 3
26 Mar 2025 //
GLOBENEWSWIRE
Traws Pharma Presents COVID-19 Candidate Ratutrelvir at ICAR
25 Mar 2025 //
GLOBENEWSWIRE
Traws Pharma`s Tivoxavir Marboxil Shows Positive Data in Primates
24 Mar 2025 //
GLOBENEWSWIRE
Traws Pharma Presents Bird Flu Drug Tivoxavir, Marboxil at ICAR
21 Mar 2025 //
GLOBENEWSWIRE
Traws Reports Positive Results For Bird Flu Drug Tivoxavir
03 Mar 2025 //
GLOBENEWSWIRE
Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule
28 Feb 2025 //
GLOBENEWSWIRE
Traws Completes Tivoxavir Phase I For H5N1 Bird Flu Treatment
23 Jan 2025 //
PR NEWSWIRE
Traws Pharma Progresses Tivoxavir Marboxil for H5N1 Bird Flu
23 Dec 2024 //
PR NEWSWIRE
Traws Pharma Provides Update & Reports Q3 2024 Financial Results
14 Nov 2024 //
GLOBENEWSWIRE
Traws Pharma Reports Positive Ph 1 Results For COVID Candidate
30 Sep 2024 //
GLOBENEWSWIRE
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
20 Sep 2024 //
GLOBENEWSWIRE
Traws Pharma, Inc. Announces Special Shareholders Meeting Results
17 Sep 2024 //
GLOBENEWSWIRE
Traws Pharma Reports Q2 2024 Results And Recent Business Highlights
15 Aug 2024 //
GLOBENEWSWIRE
Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
14 Aug 2024 //
GLOBENEWSWIRE
Traws Pharma`s ICAR Poster Highlights Potency of COVID-19 Candidate
23 May 2024 //
GLOBENEWSWIRE
Traws Pharma Reports Q1 2024 Financials, Business Update
16 May 2024 //
GLOBENEWSWIRE
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
07 May 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.